WangN-S, HuangS-N, GoldP.. Absence of carcinoembryonic antigen-like material in mesothelioma. An immunohistochemical differentiation from other lung cancers.Cancer1979; 44: 937–43
2.
WhitakerD., ShilkinK.B.. Diagnosis of pleural malignant mesothelioma in life - a practical approach.J Pathol1984; 143: 147–75
3.
CorsonJ.M., PinkusG.S.. Mesothelioma: profile of keratin proteins and carcinoembryonic antigen. An immunoperoxidase study of 20 cases and comparison with pulmonary adenocarcinomas.Am J Pathol1982; 108: 80–7
4.
SaidJ.W., NashG., TepperG., Banks-SchlegelS.. Keratin proteins and carcinoembryonic antigen in lung carcinoma. An immunoperoxidase study of fifty-four cases, with ultrastructural correlations.Hum Pathol1983; 14: 70–6
5.
HoldenJ., ChurgA.. Immunohistochemical staining for keratin and carcinoembryonic antigen in the diagnosis of malignant mesothelioma.Am J Surg Pathol1984; 8: 277–9
6.
BattiforaH., KopinskiM.I.. Distinction of mesothelioma from adenocarcinomas. An immunohistochemical approach.Cancer1985; 55: 1679–85
7.
HeydermanE., LarkinS.E., MakinC.A., CorrinB.. Epithelial markers in pleural mesotheliomas. A comparison with primary lung carcinoma.J Pathol1985; 145: 81A
8.
MakinC.A., BobrowL.G., BodmerW.F.. Monoclonal antibody to cytokeratin for use in routine histopathology.J Clin Pathol1984; 37: 975–83
9.
TwiningS.S., BrecherA.S.. Isolation and identification of α1-antitrypsin as a component of normal and malignant human breast and other tissues.Proc Soc Exp Biol Med1975; 150: 98–103
10.
KittasC., AroniK., KotsisL., PapadimitriouC.S.. Distribution of lysozyme, a-1antichymotrypsin and α1-antitrypsin in adenocarcinomas of the stomach and large intestine. An immunohistochemical study.Virchows Arch [Pathol Anat]1982; 398: 139–47
11.
BurchellJ., DurbinH., Taylor-PapadimitriouJ.. Complexity of expression of antigenic determinants, recognised by monoclonal antibodies HMFG-1 and HMFG-2, in normal and malignant human mammary epithelial cells.J Immunol1983; 131: 508–13
12.
HeydermanE., SteeleK., OrmerodM.G.. A new antigen on the epithelial membrane: its immunoperoxidase localisation in normal and neoplastic tissue.J Clin Pathol1979; 32: 35–9
13.
HeydermanE., StrudleyI., PowellG., RichardsonT.C., CordellJ.L., MasonD.Y.. A new monoclonal antibody to epithelial membrane antigen (EMA)-E29. A comparison of its immunocytochemical reactivity with polyclonal anti-EMA antibodies and with another monoclonal antibody, HMFG-2.Br J Cancer1985; 52: 355–61
14.
BlobelG.A., MollR., FrankeW.W., KayserK.W., GouldV.E.. The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance.Am J Pathol1985; 121: 235–47
15.
ChurgA.. Immunohistochemical staining for vimentin and keratin in malignant mesothelioma.Am J Surg Pathol1985; 9: 360–5
16.
GatterK.G., DunnillM.S., Van MuijenG.N.P., MasonD.Y.. Human lung tumours may coexpress different classes of intermediate filaments.J Clin Pathol1986; 39: 950–4
17.
LeeI., RadesovichJ.A., ChejfecG., YixingM.A., WarrenW.H., RosenS.T., GouldV.E.. Malignant mesotheliomas. Improved differential diagnosis from lung adenocarcinomas using monoclonal antibodies 44-3A6 and 624A12.Am J Pathol1986; 123: 497–507
18.
DewarA., ValenteM., RingN.P., CorrinB.. Pleural mesothelioma of epithelial type and pulmonary adenocarcinoma: an ultrastructural and cytochemical comparison.J Pathol1987; 152: 309–16
19.
KweeW.S., VeldhuizenR.W., GoldingR.P., MullinkH., StamJ., DonnerR., BoonM.E.. Histologic distinction between malignant mesothelioma, benign pleural lesion and carcinoma metastasis. Evaluation of the application of morphometry combined with histochemistry and immunostaining.Virchows Arch [Pathol Anat]1982; 397: 287–99
20.
NortonA.J., ThomasJ.A., IsaacsonP.G.. Cytokeratin-specific monoclonal antibodies are reactive with tumours of smooth muscle derivation. An immunocytochemical and biochemical study using antibodies to intermediate filament cytoskeletal proteins.Histopathology1987; 11: 487–99